Top Markets
Coin of the day
Photocure ASA Photocure ASA

Photocure ASA

PHO
Rank in Stocks #19788
Photocure ASA is a specialized pharmaceutical enterprise focused on the... Photocure ASA is a specialized pharmaceutical enterprise focused on the development, manufacturing, commercialization, and distribution of medicinal products. Its operational footprint extends across multiple European nations, including the Nordic region, Germany, France, Austria, the United Kingdom, the Netherlands, and Italy, in addition to the United States. The company's primary offering, Hexvix/Cysview, aids in the identification and ongoing management of bladder cancer. Moreover, Photocure is actively progressing Cevira, a therapeutic agent in development targeting human papilloma virus (HPV) infections and pre-cancerous lesions of the cervix. The firm distributes its products to pharmaceutical wholesalers, pharmacies, and healthcare institutions through collaborative licensing arrangements. Founded in 1993, Photocure ASA maintains its corporate headquarters in Oslo, Norway.
Share Price
$5.66
Last synced: 2026-08-25
Market Cap
$150.59M
Change (1 day)
0.00%
Change (1 year)
-7.22%
Country
NO
Trade Photocure ASA (PHO)

Category

Stock price history for Photocure ASA (PHO)
Highest end of day price: $5.66 on 2026-08-01

Lowest end of day price: $15.58 on 2000-05-01
Stock price history of Photocure ASA from 2000 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -2.96%
2025 28.54%
2024 -13.50%
2023 -44.95%
2022 -1.10%
2021 6.04%
2020 6.94%
2019 100.51%
2018 56.22%
2017 -42.69%
2016 22.45%
2015 38.79%
2014 -36.85%
2013 -24.72%
2012 19.86%
2011 -23.40%
2010 -11.84%
2009 145.99%
2008 -58.34%
2007 -10.45%
2006 15.59%
2005 24.20%
2004 -18.80%
2003 53.00%
2002 -59.24%
2001 38.20%
2000 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$123.16 -11.88%
AU
$772.27 7.33%
CH